Exploring GLP-1 drugs for Alzheimer’s prevention
March 30, 2026
University of Cincinnati researchers, funded by the NIH, are studying how GLP-1 drugs may help prevent Alzheimer’s disease by analyzing real-world data from patients with mild cognitive impairment. Learn more about this groundbreaking UC Alzheimer’s research.